Evaluating the Impact of 1.60 Increase on Immunovant Inc’s (IMVT) Stock
The stock of Immunovant Inc (IMVT) has seen a 4.24% increase in the past week, with a 7.32% gain in the past month, and a
The stock of Immunovant Inc (IMVT) has seen a 4.24% increase in the past week, with a 7.32% gain in the past month, and a
Company’s 36-month beta value is 0.71.Analysts have differing opinions on the stock, with 8 analysts rating it as a “buy,” 7 as “overweight,” 0 as
Moreover, the 36-month beta value for IMVT is 0.71. Analysts have varying opinions on the stock, with 8 analysts rating it as a “buy,” 7
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.